Total Payments
$1,545
2024 Payments
$255.95
Companies
18
Transactions
70
Medicare Patients
4,928
Medicare Billing
$351,120
Payment Breakdown by Category
Food & Beverage$1,376 (89.0%)
Other$150.00 (9.7%)
Gifts$19.40 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,376 | 68 | 89.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 1 | 9.7% |
| Gift | $19.40 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $433.84 | 22 | $0 (2024) |
| Shire North American Group Inc | $218.21 | 6 | $0 (2018) |
| CooperVision Inc. | $183.91 | 7 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $157.64 | 8 | $0 (2023) |
| Allergan, Inc. | $136.30 | 7 | $0 (2022) |
| Oyster Point Pharma, Inc. | $110.08 | 5 | $0 (2024) |
| Genentech USA, Inc. | $45.95 | 1 | $0 (2019) |
| Bausch & Lomb Americas Inc. | $39.03 | 2 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $34.49 | 2 | $0 (2024) |
| Johnson & Johnson Vision Care, Inc. | $33.79 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $255.95 | 17 | ABBVIE INC. ($153.82) |
| 2023 | $343.60 | 14 | AbbVie Inc. ($211.05) |
| 2022 | $170.80 | 8 | ABBVIE INC. ($68.97) |
| 2021 | $86.94 | 4 | SUN PHARMACEUTICAL INDUSTRIES INC. ($56.30) |
| 2020 | $62.14 | 4 | Sun Pharmaceutical Industries Inc. ($30.89) |
| 2019 | $151.07 | 7 | Sun Pharmaceutical Industries Inc. ($54.27) |
| 2018 | $330.56 | 9 | Shire North American Group Inc ($205.34) |
| 2017 | $144.33 | 7 | CooperVision Inc. ($80.62) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: EYE CARE | ||||||
| 10/23/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: EYE CARE | ||||||
| 09/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/16/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: EYE CARE | ||||||
| 08/27/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: EYE CARE | ||||||
| 08/27/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Ophthalmology | ||||||
| 07/30/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: EYE CARE | ||||||
| 06/27/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: EYE CARE | ||||||
| 05/28/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: EYE CARE | ||||||
| 04/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: EYE CARE | ||||||
| 04/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Dry eyes | ||||||
| 03/20/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: SOLUTION/ DROPS | ||||||
| 03/05/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: EYE CARE | ||||||
| 02/29/2024 | ABBVIE INC. | ALPHAGAN P (Drug), COMBIGAN, VUITY | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: EYE CARE | ||||||
| 01/31/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: EYE CARE | ||||||
| 01/24/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 01/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: EYE CARE | ||||||
| 12/21/2023 | AbbVie Inc. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: EYE CARE | ||||||
| 11/28/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: EYE CARE | ||||||
| 10/25/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: EYE CARE | ||||||
| 10/02/2023 | AbbVie Inc. | VUITY (Drug) | Food and Beverage | In-kind items and services | $115.74 | General |
| Category: EYE CARE | ||||||
| 09/13/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $17.46 | General |
| 08/22/2023 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Ophthalmology | ||||||
| 08/17/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Ophthalmology | ||||||
| 06/17/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: DRY EYE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,127 | 3,790 | $201,981 | $75,743 |
| 2022 | 9 | 1,106 | 5,253 | $205,786 | $75,554 |
| 2021 | 11 | 1,429 | 5,614 | $263,020 | $104,746 |
| 2020 | 8 | 1,266 | 7,600 | $231,508 | $95,076 |
Total Patients
4,928
Total Services
22,257
Medicare Billing
$351,120
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 591 | 630 | $110,250 | $47,220 | 42.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 187 | 248 | $27,280 | $14,128 | 51.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 118 | 139 | $26,758 | $5,576 | 20.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 126 | 130 | $16,250 | $3,085 | 19.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 18 | 2,554 | $9,084 | $2,319 | 25.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 14 | 14 | $3,010 | $1,485 | 49.3% |
| 92134 | Imaging of retina | Office | 2023 | 46 | 48 | $6,000 | $1,349 | 22.5% |
| 92250 | Photography of the retina | Office | 2023 | 12 | 12 | $2,112 | $307.91 | 14.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 15 | 15 | $1,238 | $273.78 | 22.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 582 | 621 | $108,675 | $46,241 | 42.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 173 | 256 | $28,160 | $14,436 | 51.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 109 | 130 | $25,025 | $5,265 | 21.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2022 | 31 | 4,027 | $14,789 | $3,720 | 25.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 123 | 128 | $16,000 | $2,923 | 18.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 21 | 21 | $4,515 | $1,233 | 27.3% |
| 92134 | Imaging of retina | Office | 2022 | 43 | 46 | $5,750 | $1,222 | 21.3% |
| 92250 | Photography of the retina | Office | 2022 | 11 | 11 | $1,799 | $280.78 | 15.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 13 | 13 | $1,073 | $233.62 | 21.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 648 | 694 | $121,450 | $54,335 | 44.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 232 | 370 | $40,700 | $21,628 | 53.1% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 139 | 139 | $29,885 | $13,563 | 45.4% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 118 | 125 | $24,063 | $5,266 | 21.9% |
| 66984 | Removal of cataract with insertion of lens, simple | Office | 2021 | 32 | 4,019 | $14,520 | $3,796 | 26.1% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 140 | 145 | $18,125 | $3,405 | 18.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 52 | 52 | $6,500 | $1,505 | 23.2% |
About Dr. David Douglass, OD
Dr. David Douglass, OD is a Optometrist healthcare provider based in Bangor, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417949678.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Douglass, OD has received a total of $1,545 in payments from pharmaceutical and medical device companies, with $255.95 received in 2024. These payments were reported across 70 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,376).
As a Medicare-enrolled provider, Douglass has provided services to 4,928 Medicare beneficiaries, totaling 22,257 services with total Medicare billing of $351,120. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Bangor, ME
- Active Since 08/15/2005
- Last Updated 01/16/2025
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417949678
Products in Payments
- LUMIGAN (Drug) $273.89
- VUITY (Drug) $161.85
- Clariti Contact Lens (Device) $153.33
- TYRVAYA (Drug) $110.08
- XIIDRA (Drug) $91.80
- Cequa (Drug) $72.48
- ALPHAGAN P (Drug) $53.53
- Lucentis (Biological) $45.95
- CEQUA (Drug) $35.01
- XDEMVY (Drug) $34.49
- Acuvue (Device) $33.79
- XELPROS (Drug) $31.76
- ULTRA (Device) $25.00
- DURYSTA (Drug) $24.69
- VYZULTA (Drug) $21.18
- OXERVATE (Drug) $20.26
- Contact Lens (Device) $20.00
- None Specified (Medical Supply) $19.40
- RESTASIS (Drug) $19.14
- MyDay Contact Lens (Device) $18.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Bangor
Dr. Lindsay Michaud, Od, OD
Optometrist — Payments: $1,935
Optometrist $1,935
Luke Gamble, O.d, O.D
Optometrist — Payments: $1,732
Optometrist $1,732
Ethan Taylor, O.d, O.D
Optometrist — Payments: $1,453
Optometrist $1,453
Dr. Philip Goldthwait, O.d, O.D
Optometrist — Payments: $1,209
Optometrist $1,209
Katherine Nickerson, O.d, O.D
Optometrist — Payments: $1,147
Optometrist $1,147
Dr. Christopher Nowik, O.d, O.D
Optometrist — Payments: $1,039
Optometrist $1,039